Company Description
Enzon Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and sell human therapeutics for life-threatening diseases. The Group includes three segments: Product sale which manufactures markets and sells pharmaceutical ...
More
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
E
Enzon
A biopharmaceutical company that developing advanced therapeutics for life-threatening diseases through the application of its proprietary technologies, PEG-Modification and Single-Chain Antigen-Binding (SCA®) proteins.
www.enzon.com
A biopharmaceutical company that developing advanced therapeutics for life-threatening diseases through the application of its proprietary technologies, PEG-Modification and Single-Chain Antigen-Binding (SCA®) proteins.
www.enzon.com
Breaking News
Reuters - Nov. 19, 2009, 7:03 AM
ABC News - Nov. 9, 2009, 9:44 AM
Reuters - Nov. 9, 2009, 8:40 AM
Forbes.com - Oct. 28, 2009, 12:43 PM
